Tokyo, Japan — October 2, 2025 — Leads & Copy — A.D.A.M. Innovations Co., a leading genomics and AI company in Japan, has launched GeneLink, a new advertising platform. GeneLink combines genetics, lifestyle insights, and artificial intelligence to deliver precision marketing.
GeneLink moves beyond traditional demographic and behavioral targeting by integrating biological predispositions. Built on Japan’s largest genomic database, it allows brands to engage with audiences on a deeper level while respecting privacy and delivering results.
Michel Mommejat, President of A.D.A.M. Innovations, stated that GeneLink transforms how brands and individuals connect by combining AI with genetic and lifestyle insights. GeneLink empowers marketers with precision, while giving individuals value, trust, and rewards for sharing their data.
Key features include genetic and lifestyle precision via AI-driven targeting, privacy by design with consent-based and encrypted data, a shared-economy model where users earn GeneLife Points, and targeted solutions for marketers, such as DNA-informed product sampling. GeneLink uses the largest genomic database of the Japanese population to deliver insights and precision.
Launching first in Japan, GeneLink will expand internationally. Unlike traditional ad-tech platforms, GeneLink transforms advertising into a force for wellness, prevention, and healthier living, ensuring value flows back to individuals, brands, and society as a whole.
Corporate contact:
Email: press@adam-innnovations.com
Media Relations: Crocker Coulson
Email: Crocker.Coulson@aumadvisors.com
+1 (646) 652-7185
Source: A.D.A.M. Innovations Co.
